Literature DB >> 22430106

Neuro-oncology: Glioblastoma--community adjusts to new standard of care.

Annick Desjardins, Henry S Friedman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22430106     DOI： 10.1038/nrneurol.2012.42

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

Review 1.  Recent developments in the use of chemotherapy in brain tumours.

Authors:  Martin J van den Bent; Monika E Hegi; Roger Stupp
Journal:  Eur J Cancer       Date:  2006-01-20       Impact factor: 9.162

2.  Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006.

Authors:  K Robin Yabroff; Linda Harlan; Christopher Zeruto; Jeffrey Abrams; Bhupinder Mann
Journal:  Neuro Oncol       Date:  2012-01-12       Impact factor: 12.300

3.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Authors:  M Lacroix; D Abi-Said; D R Fourney; Z L Gokaslan; W Shi; F DeMonte; F F Lang; I E McCutcheon; S J Hassenbusch; E Holland; K Hess; C Michael; D Miller; R Sawaya
Journal:  J Neurosurg       Date:  2001-08       Impact factor: 5.115

4.  Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.

Authors:  Kazuya Motomura; Atsushi Natsume; Yugo Kishida; Hiroyuki Higashi; Yutaka Kondo; Yoko Nakasu; Tatsuya Abe; Hiroki Namba; Kenji Wakai; Toshihiko Wakabayashi
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

5.  Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

Authors:  Nicholas Butowski; Susan M Chang; Kathleen R Lamborn; Mei-Yin Polley; Russell Pieper; Joseph F Costello; Scott Vandenberg; Rupa Parvataneni; Angelina Nicole; Patricia K Sneed; Jennifer Clarke; Emily Hsieh; Bruno M Costa; Rui M Reis; Maria Hristova-Kazmierski; Steven J Nicol; Donald E Thornton; Michael D Prados
Journal:  Neuro Oncol       Date:  2011-09-06       Impact factor: 12.300

6.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.

Authors:  Stuart A Grossman; Xiaobu Ye; Marc Chamberlain; Tom Mikkelsen; Tracy Batchelor; Serena Desideri; Steven Piantadosi; Joy Fisher; Howard A Fine
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

Review 9.  Glioma extent of resection and its impact on patient outcome.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654
  9 in total
  2 in total

1.  Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Authors:  Aurélien Corroyer-Dulmont; Elodie A Pérès; Edwige Petit; Jean-Sébastien Guillamo; Nathalie Varoqueaux; Simon Roussel; Jérôme Toutain; Didier Divoux; Eric T MacKenzie; Jérôme Delamare; Méziane Ibazizène; Myriam Lecocq; Andréas H Jacobs; Louisa Barré; Myriam Bernaudin; Samuel Valable
Journal:  Neuro Oncol       Date:  2012-10-31       Impact factor: 12.300

2.  Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.

Authors:  Aurélien Corroyer-Dulmont; Elodie A Pérès; Aurélie N Gérault; Ariel Savina; Fanny Bouquet; Didier Divoux; Jérôme Toutain; Méziane Ibazizène; Eric T MacKenzie; Louisa Barré; Myriam Bernaudin; Edwige Petit; Samuel Valable
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-05       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.